Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
In-office chemo costs less
Winn A et al., JAMA Oncol. 2018 Feb 22. doi: 10.1001/jamaoncol.2017.5544.
Key clinical point:
Major finding: Total reimbursement during the 6-month treatment episode was lower in offices ($43,700) than in hospital outpatient departments ($84,660).
Study details: An examination of claims data from 283,502 patients who initiated treatment with infused chemotherapy and remained enrolled continuously for 6 months between Jan. 1, 2004, and Dec. 31, 2014.
Disclosures: The researchers reported having no financial conflicts of interest.
Citation:
Source: Winn A et al., JAMA Oncol. 2018 Feb 22. doi: 10.1001/jamaoncol.2017.5544.